Peer-driven intervention to prevent HIV, HCV, and drug overdoses among people who inject drugs
A Geospatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs in Baltimore, Maryland
This study is testing whether getting support and education from peers can help people who inject drugs reduce their risk of HIV, hepatitis C, and overdoses.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 285 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT05320835 on ClinicalTrials.gov |
What this trial studies
This pilot intervention focuses on reducing the transmission of HIV and hepatitis C virus, as well as overdose risk behaviors among people who inject drugs (PWID). Participants will be randomized into groups receiving peer education and access to risk reduction materials in semi-public injection settings, alongside standard care. The intervention is grounded in social influence and cognitive theories, aiming to enhance communication about risk behaviors and improve social norms. By increasing the availability of risk reduction materials and promoting peer outreach, the study seeks to reduce the sharing of injection equipment and improve naloxone access.
Who should consider this trial
Good fit: Ideal candidates for this study are current drug users, specifically those who have used opioids in the past two weeks.
Not a fit: Patients with any mental or physical health impairments that hinder their ability to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly lower the rates of HIV and HCV transmission and reduce overdose incidents among PWID.
How similar studies have performed: Previous studies have shown promise in using peer-driven interventions to address similar issues, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current drug user (opioid use in the prior two weeks) Exclusion Criteria: * Any mental or physical health impairment that impedes ability to participate
Where this trial is running
Baltimore, Maryland
- Lighthouse Studies at Peer Point — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Carl Latkin, PhD — Johns Hopkins Bloomberg School of Public Health
- Study coordinator: Carl Latkin, PhD
- Email: carl.latkin@jhu.edu
- Phone: 410-955-3972
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.